Cancer trials. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Neoplastic Stem Cells Breast Prostate Tumor Cells, Cultured HCT116 Cells MCF-7 Cells HT29 Cells

Organisms3

Mice, Nude Mice, SCID Mice, Inbred BALB C

Diseases47

Neoplasms Breast Neoplasms Rectal Neoplasms Lung Neoplasms Neoplasm Recurrence, Local Prostatic Neoplasms Ovarian Neoplasms Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Neoplasm Invasiveness Pancreatic Neoplasms Disease Progression Uterine Cervical Neoplasms Carcinoma, Non-Small-Cell Lung Genetic Predisposition to Disease Colorectal Neoplasms Carcinoma Carcinoma, Squamous Cell Urinary Bladder Neoplasms Lymphatic Metastasis Endometrial Neoplasms Cell Transformation, Neoplastic Esophageal Neoplasms Adenocarcinoma Head and Neck Neoplasms Liver Neoplasms Carcinoma, Small Cell Neoplasms, Hormone-Dependent Bone Neoplasms Mouth Neoplasms Skin Neoplasms Neoplasms, Second Primary Neoplasms, Glandular and Epithelial Neoplasms, Radiation-Induced Neovascularization, Pathologic Genital Neoplasms, Female Gastrointestinal Neoplasms Precancerous Conditions Recurrence Melanoma Thyroid Neoplasms Kidney Neoplasms Mammary Neoplasms, Experimental Disease Models, Animal Pharyngeal Neoplasms Neoplasms, Multiple Primary

Chemicals and Drugs49

Antineoplastic Agents Tamoxifen Fluorouracil Antineoplastic Agents, Hormonal Cisplatin Tumor Markers, Biological Selenium Cyclophosphamide Cancer Vaccines Neoplasm Proteins Receptors, Estrogen Receptor, erbB-2 RNA, Messenger Prostate-Specific Antigen DNA, Neoplasm Paclitaxel Antineoplastic Agents, Phytogenic RNA, Small Interfering Tumor Suppressor Protein p53 Placebos Antibodies, Monoclonal Antigens, Neoplasm Receptors, Progesterone Anticarcinogenic Agents Deoxycytidine Antibodies, Monoclonal, Humanized Taxoids Antimetabolites, Antineoplastic Receptor, Epidermal Growth Factor MicroRNAs Tumor Suppressor Proteins Receptors, Androgen RNA, Neoplasm DNA-Binding Proteins Protein Kinase Inhibitors Quinazolines Estrogens BRCA2 Protein Androgens Organoplatinum Compounds Proto-Oncogene Proteins Transcription Factors Androgen Antagonists Carcinogens BRCA1 Protein Proto-Oncogene Proteins c-akt Nuclear Proteins Camptothecin Antibiotics, Antineoplastic

Analytical, Diagnostic and Therapeutic Techniques and Equipment89

Clinical Trials as Topic Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Research Design Chemotherapy, Adjuvant Antineoplastic Combined Chemotherapy Protocols Patient Selection Treatment Outcome Disease-Free Survival Multicenter Studies as Topic Early Detection of Cancer Randomized Controlled Trials as Topic Survival Rate Survival Analysis Endpoint Determination Combined Modality Therapy Prognosis Radiotherapy, Adjuvant Sample Size Neoplasm Staging Retrospective Studies Follow-Up Studies Prospective Studies Neoadjuvant Therapy Double-Blind Method Risk Risk Assessment Registries Reverse Transcriptase Polymerase Chain Reaction Xenograft Model Antitumor Assays Gene Expression Profiling Risk Factors Drug Administration Schedule Questionnaires Odds Ratio Proportional Hazards Models Controlled Clinical Trials as Topic Kaplan-Meier Estimate Sensitivity and Specificity Neoplasm Transplantation Multivariate Analysis Blotting, Western Reproducibility of Results Placebos Predictive Value of Tests Transplantation, Heterologous Mammography Molecular Targeted Therapy Logistic Models Pilot Projects Tumor Burden Drug Screening Assays, Antitumor Oligonucleotide Array Sequence Analysis Confidence Intervals SEER Program Clinical Protocols Incidence Polymerase Chain Reaction Radiotherapy Single-Blind Method Models, Biological Early Termination of Clinical Trials Feasibility Studies Transfection Neoplasm Grading Administration, Oral Palliative Care Immunotherapy Tissue Array Analysis Flow Cytometry Drug Therapy, Combination Biopsy Mastectomy Infusions, Intravenous Immunoenzyme Techniques Gene Knockdown Techniques Cluster Analysis Mammary Neoplasms, Experimental Analysis of Variance Drug Delivery Systems Cohort Studies Chi-Square Distribution Disease Models, Animal Regression Analysis Genetic Therapy Chemoprevention Genetic Testing Radiotherapy Dosage

Psychiatry and Psychology2

Smoking Patient Compliance

Phenomena and Processes41

Gene Expression Regulation, Neoplastic Risk Genetic Predisposition to Disease Drug Resistance, Neoplasm Mutation Odds Ratio Dose-Response Relationship, Drug Time Factors Sensitivity and Specificity DNA Methylation Cell Survival Genotype Down-Regulation Cell Movement Genes, BRCA1 Cell Division Polymorphism, Genetic Cell Proliferation Apoptosis Diet Cell Cycle Postmenopause Cell Growth Processes Promoter Regions, Genetic Transfection RNA Interference Up-Regulation Gene Silencing Genes, Tumor Suppressor Genes, Neoplasm Germ-Line Mutation Genes, p53 Phenotype Gene Expression Base Sequence Genes, BRCA2 Signal Transduction Chi-Square Distribution Drug Synergism Phosphorylation Menopause

Disciplines and Occupations3

Research Design Medical Oncology Outcome Assessment (Health Care)

Anthropology, Education, Sociology and Social Phenomena4

National Cancer Institute (U.S.)Informed Consent Quality of Life Patient Education as Topic

Technology, Industry, Agriculture1

Dietary Supplements

Humanities1

Quality of Life

Information Science7

Survival Rate Registries Questionnaires SEER Program Incidence Base Sequence Molecular Sequence Data

Named Groups2

Survivors European Continental Ancestry Group

Health Care55

Clinical Trials as Topic Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic National Cancer Institute (U.S.)Patient Selection Treatment Outcome Disease-Free Survival Multicenter Studies as Topic Randomized Controlled Trials as Topic Survival Rate Survival Analysis Informed Consent Sample Size Retrospective Studies Follow-Up Studies Prospective Studies Double-Blind Method Risk Risk Assessment Registries Risk Factors Age Factors Questionnaires Odds Ratio Proportional Hazards Models Controlled Clinical Trials as Topic Kaplan-Meier Estimate Sensitivity and Specificity Multivariate Analysis Reproducibility of Results Predictive Value of Tests Logistic Models Pilot Projects Confidence Intervals SEER Program Clinical Protocols Incidence American Cancer Society Single-Blind Method Cost-Benefit Analysis Early Termination of Clinical Trials Feasibility Studies Palliative Care Cluster Analysis Outcome Assessment (Health Care)Analysis of Variance Cohort Studies Chi-Square Distribution Clinical Trials Data Monitoring Committees Patient Compliance Regression Analysis Genetic Testing Sex Factors Patient Education as Topic

Geographicals6

United States Japan China Europe Great Britain Sweden

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Clinical Trials as Topic Clinical Trials, Phase I as Topic Clinical Trials, Phase II as Topic Clinical Trials, Phase III as Topic Neoplasms National Cancer Institute (U.S.)Research Design Breast Neoplasms Chemotherapy, Adjuvant Rectal Neoplasms Antineoplastic Combined Chemotherapy Protocols Patient Selection Lung Neoplasms Treatment Outcome Disease-Free Survival Multicenter Studies as Topic Antineoplastic Agents Early Detection of Cancer Randomized Controlled Trials as Topic Survival Rate Survival Analysis Endpoint Determination Tamoxifen Combined Modality Therapy Fluorouracil Prognosis Neoplasm Recurrence, Local Informed Consent Radiotherapy, Adjuvant United States Sample Size Antineoplastic Agents, Hormonal Prostatic Neoplasms Neoplasm Staging Cisplatin Tumor Markers, Biological Ovarian Neoplasms Selenium Quality of Life Retrospective Studies Stomach Neoplasms Colonic Neoplasms Neoplasm Metastasis Cyclophosphamide Follow-Up Studies Neoplasm Invasiveness Prospective Studies Pancreatic Neoplasms Cancer Vaccines Neoadjuvant Therapy Mice, Nude Gene Expression Regulation, Neoplastic Double-Blind Method Disease Progression Neoplasm Proteins Uterine Cervical Neoplasms Risk Carcinoma, Non-Small-Cell Lung Risk Assessment Genetic Predisposition to Disease Colorectal Neoplasms Drug Resistance, Neoplasm Carcinoma Carcinoma, Squamous Cell Urinary Bladder Neoplasms Registries Cell Line, Tumor Reverse Transcriptase Polymerase Chain Reaction Receptors, Estrogen Xenograft Model Antitumor Assays Gene Expression Profiling Risk Factors Drug Administration Schedule Age Factors Lymphatic Metastasis Questionnaires Mutation Survivors Receptor, erbB-2 Odds Ratio Proportional Hazards Models Dose-Response Relationship, Drug RNA, Messenger Controlled Clinical Trials as Topic Time Factors Medical Oncology Kaplan-Meier Estimate Prostate-Specific Antigen Smoking Sensitivity and Specificity Neoplasm Transplantation Multivariate Analysis Endometrial Neoplasms Blotting, Western DNA, Neoplasm Cell Transformation, Neoplastic Paclitaxel Antineoplastic Agents, Phytogenic RNA, Small Interfering Esophageal Neoplasms

No FAQ available that match "cancer trials"